Clinical Trial Update: A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating the efficacy and safety of finerenone in adults with non-diabetic chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: Bayer | Conditions: Non-diabetic Chronic Kidney Disease | Phase 3 | Status: COMPLETED